Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE)

robot
Abstract generation in progress

Xenon Pharmaceuticals (NASDAQ:XENE) experienced unusually high options trading activity, with traders acquiring 4,063 put options, a 2,362% increase over the average, signaling bearish sentiment. This comes despite the stock having a consensus “Buy” rating and trading higher on the reported day. The article also notes significant insider selling, including a large transaction by the CEO, alongside institutional inflows and various analyst ratings.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin